This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Mar;21(3):152-61.

doi: 10.1097/FPC.0b013e3283385a1c.

Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)

Laura M Hodges¹, Svetlana M Markova, Leslie W Chinn, Jason M Gow, Deanna L Kroetz, Teri E Klein, Russ B Altman

Affiliations

PMID: 20216335
PMCID: PMC3098758
DOI: 10.1097/FPC.0b013e3283385a1c

Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein)

Laura M Hodges et al. Pharmacogenet Genomics. 2011 Mar.

. 2011 Mar;21(3):152-61.

doi: 10.1097/FPC.0b013e3283385a1c.

Authors

Laura M Hodges¹, Svetlana M Markova, Leslie W Chinn, Jason M Gow, Deanna L Kroetz, Teri E Klein, Russ B Altman

Affiliation

¹ Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.

PMID: 20216335
PMCID: PMC3098758
DOI: 10.1097/FPC.0b013e3283385a1c

No abstract available

PubMed Disclaimer

Similar articles

Multidrug resistance in epilepsy: a pharmacogenomic update.
Tate SK, Sisodiya SM. Tate SK, et al. Expert Opin Pharmacother. 2007 Jul;8(10):1441-9. doi: 10.1517/14656566.8.10.1441. Expert Opin Pharmacother. 2007. PMID: 17661727 Review.
The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.
Stępień KM, Tomaszewski M, Tomaszewska J, Czuczwar SJ. Stępień KM, et al. Pharmacol Rep. 2012;64(5):1011-9. doi: 10.1016/s1734-1140(12)70900-3. Pharmacol Rep. 2012. PMID: 23238460 Review.
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF. Zhou SF. Xenobiotica. 2008 Jul;38(7-8):802-32. doi: 10.1080/00498250701867889. Xenobiotica. 2008. PMID: 18668431 Review.
Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR Jr, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Cancer Res. 2008 Oct 1;68(19):7905-14. doi: 10.1158/0008-5472.CAN-08-0499. Cancer Res. 2008. PMID: 18829547 Free PMC article.
Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function.
Dai CL, Liang YJ, Chen LM, Zhang X, Deng WJ, Su XD, Shi Z, Wu CP, Ashby CR Jr, Akiyama S, Ambudkar SV, Chen ZS, Fu LW. Dai CL, et al. Biochem Pharmacol. 2009 Aug 15;78(4):355-64. doi: 10.1016/j.bcp.2009.04.023. Epub 2009 May 3. Biochem Pharmacol. 2009. PMID: 19410561 Free PMC article.

See all similar articles

Cited by

Interindividual epigenetic variation in ABCB1 promoter and its relationship with ABCB1 expression and function in healthy Chinese subjects.
Wu LX, Wen CJ, Li Y, Zhang X, Shao YY, Yang Z, Zhou HH. Wu LX, et al. Br J Clin Pharmacol. 2015 Nov;80(5):1109-21. doi: 10.1111/bcp.12675. Epub 2015 May 28. Br J Clin Pharmacol. 2015. PMID: 25940551 Free PMC article. Clinical Trial.
Characterization of Chemoresistance in Pancreatic Cancer: A Look at MDR-1 Polymorphisms and Expression in Cancer Cells and Patients.
Girolimetti G, Balena B, Cordella P, Verri T, Eusebi LH, Bozzetti MP, Bucci C, Guerra F. Girolimetti G, et al. Int J Mol Sci. 2024 Aug 4;25(15):8515. doi: 10.3390/ijms25158515. Int J Mol Sci. 2024. PMID: 39126083 Free PMC article.
Influence of AGTR1 and ABCB1 Gene Polymorphism on the Curative Effect of Irbesartan.
Wang Q, You L, Li Z, Zhang L, Li X, Yang X. Wang Q, et al. Int J Hypertens. 2022 Nov 9;2022:4278675. doi: 10.1155/2022/4278675. eCollection 2022. Int J Hypertens. 2022. PMID: 36404948 Free PMC article.
Pharmacogenomics-based individualized treatment of hypertension in preterm infants: A case report and review of the literature.
Tang LF, Xu A, Liu K. Tang LF, et al. World J Clin Cases. 2023 Oct 26;11(30):7440-7449. doi: 10.12998/wjcc.v11.i30.7440. World J Clin Cases. 2023. PMID: 37969466 Free PMC article.
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance.
Noetzli M, Guidi M, Ebbing K, Eyer S, Wilhelm L, Michon A, Thomazic V, Stancu I, Alnawaqil AM, Bula C, Zumbach S, Gaillard M, Giannakopoulos P, von Gunten A, Csajka C, Eap CB. Noetzli M, et al. Br J Clin Pharmacol. 2014 Jul;78(1):135-44. doi: 10.1111/bcp.12325. Br J Clin Pharmacol. 2014. PMID: 24433464 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Jones PM, George AM. The ABC transporter structure and mechanism: perspectives on recent research. Cell Mol Life Sci. 2004;61:682–699. - PMC - PubMed
1. Rosenberg MF, Callaghan R, Ford RC, Higgins CF. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J Biol Chem. 1997;272:10685–10694. - PubMed
1. Croop JM. P-glycoprotein structure and evolutionary homologies. Cytotechnology. 1993;12:1–32. - PubMed
1. Borst P, Elferink RO. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537–592. - PubMed
1. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol. 1999;39:361–398. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov